Quest Diagnostics Corporate Profile

Article submitted by Quest Diagnostics.
For more information, visit their website: www.questdiagnostics.com.

Quest Diagnostics Incorporated (NYSE: DGX) is the nation's leading provider of diagnostic testing, information and services, with 2003 revenues of $4.7 billion and 37,000 employees. It provides insights that enable physicians, hospitals, managed care organizations and other healthcare professionals to make decisions to improve health.

Quest Diagnostics offers the broadest access to diagnostic testing services through its network of more than 30 full-service laboratories in major metropolitan markets across the United States and in Mexico and the United Kingdom. In addition, the company operates 155 smaller, rapid-response laboratories. The company's world-renowned Nichols Institute in San Juan Capistrano, California, and Chantilly, Virginia, specializes in esoteric testing, including gene-based testing, and conducts research and development.

Patients may have their specimens collected in any of the company's nearly 2,000 conveniently located patient service centers. On a typical workday the company processes approximately 500,000 test orders. Quest Diagnostics laboratories operate 24 hours a day, 365 days a year, performing tests on behalf of more than 130 million patients each year.

Quest Diagnostics is the leader in several important health care markets, including: routine clinical testing, which includes complete blood counts, diabetes and cholesterol testing; esoteric testing, including gene-based testing, which includes HIV and hepatitis C viral load testing and specialty testing for hormones and genetic markers; non-hospital-based anatomic pathology testing, which helps physicians diagnose cancers by reviewing cells and tissue specimens, including biopsies and Pap smears; and drugs of abuse testing, which enables employers to track workplace drug use. Together with its MedPlus subsidiary, Quest Diagnostics also empowers healthcare organizations and clinicians with state-of-the-art connectivity solutions that improve patient care and practice management. Through partnerships with pharmaceutical, biotechnology and information technology companies, Quest Diagnostics provides support to help speed the development of healthcare insights and new therapeutics.